Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Sinovac

China finally approves an mRNA COVID vaccine—but only for some foreigners

Beijing's uneasy relationship with mRNA vaccines is all the more relevant as it begins to relax COVID restrictions.

Fortune

Covid antibodies offer weak defence against fast-spreading BA.5 sub-variant

Antibodies are less effective in protecting people from the stronger, now-dominant BA.5 sub-variant of Covid-19, according to the Department of Medical Sciences.

Bangkok Post

CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?

Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited benefits for the company as the pandemic fades and other products are widely available By Jony Ho

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Chinese Omicron-specific mRNA COVID vaccine candidate to be trialed in UAE

China's Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates.

Reuters

Sinovac’s Covid-19 Vaccines Give Big Boost to Shareholder’s Profits

With a 15% stake in the vaccine-maker, Sino Biopharmaceutical reports a more than fourfold surge in earnings for 2021

Caixin Global

Sinovac shot prevents only 38% of Covid cases in kids, data shows

Young children who received two doses of China’s Sinovac Biotech Ltd vaccine gained “modest” defences against Omicron infections and higher protection against developing severe cases of Covid-19, a study in Chile showed.

Bangkok Post

China allows COVID boosters of different technologies than primary shots

China is giving COVID-19 booster vaccines using technologies different from the initial injections, in an effort to improve immunisation strategies amid concerns that its most-used jabs appeared to be weaker against variants such as Omicron.

Reuters

Read news from The Economist, FT, and more,
with one subscription

COVID: China is developing its own mRNA vaccine – and it's showing early promise

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

The Conversation

Can Sinovac protect Indonesia from the Omicron wave?

Most of the vaccinated in the archipelago have been given the Sinovac shot.

Al Jazeera

Sinovac for ages 3-17 gets ministry nod

A Public Health Ministry sub-committee on immunity promotion has approved the use of Sinovac's Covid-19 vaccine on minors over the age of three, it was announced on Monday.

Bangkok Post

Sinovac applies to register vaccine for 3-year-olds

Sinovac, the manufacturer of CoronaVac Vaccine, has applied for registration of its vaccine for use with children aged three years and over, Public Health Minister Anutin Charnvirakul said on Monday.

Bangkok Post

Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows

A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ:

Benzinga

Omicron in China: New variant weakens Xi Jinping's Covid policies

BEIJING: More than two years into the pandemic most countries are striving to live alongside Covid, accepting the virus as part of everyday life. China, where the pathogen first emerged, exists in an alternate reality, wedded to a zero-tolerance strategy that’s growing harder to maintain.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Public Health Ministry

Department of Medical Sciences

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.